Alphabet Inc. - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.

Quarter-by-quarter ownership
Alphabet Inc. ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q1 2022$80,902,000
-22.0%
2,563,4410.0%2.62%
+4.8%
Q4 2021$103,742,000
-27.4%
2,563,441
-37.5%
2.50%
-26.1%
Q3 2021$142,984,000
+12.9%
4,100,475
-11.1%
3.39%
+31.4%
Q2 2021$126,695,000
-4.5%
4,613,818
-2.3%
2.58%
-51.7%
Q1 2021$132,632,000
+1.2%
4,723,348
-6.5%
5.35%
-15.0%
Q4 2020$131,092,000
+51.5%
5,049,7860.0%6.29%
+54.7%
Q3 2020$86,553,000
-30.7%
5,049,7860.0%4.07%
-29.5%
Q2 2020$124,932,000
+78.2%
5,049,7860.0%5.77%
+25.4%
Q1 2020$70,091,000
+37.4%
5,049,7860.0%4.60%
+49.1%
Q4 2019$51,003,000
+11.0%
5,049,7860.0%3.08%
+123.3%
Q3 2019$45,953,000
+14.5%
5,049,7860.0%1.38%
+81.2%
Q2 2019$40,146,000
-36.3%
5,049,7860.0%0.76%
-76.6%
Q1 2019$63,072,000
+16.0%
5,049,7860.0%3.26%
-49.3%
Q4 2018$54,386,000
-22.7%
5,049,7860.0%6.43%
-4.6%
Q3 2018$70,394,000
+13.9%
5,049,7860.0%6.74%
+29.9%
Q2 2018$61,809,000
-20.7%
5,049,7860.0%5.19%
-59.1%
Q1 2018$77,969,0005,049,78612.68%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$28,936,78218.14%
Octagon Capital Advisors LP 1,968,000$35,325,6005.43%
Decheng Capital Management III (Cayman), LLC 869,790$15,612,7315.21%
Boxer Capital, LLC 1,602,200$28,759,4901.53%
SECTORAL ASSET MANAGEMENT INC 375,456$6,739,4351.31%
DAFNA Capital Management LLC 222,717$3,997,7701.24%
PFM Health Sciences, LP 1,405,056$25,220,7551.19%
Ikarian Capital, LLC 4,000$7,180,0000.86%
Capital Impact Advisors, LLC 24,280$435,8260.73%
Parkman Healthcare Partners LLC 205,109$3,681,7070.68%
View complete list of ARCUS BIOSCIENCES INC shareholders